Výsledky vyhledávání - "L. Fernández de la Fuente Bursón"

AB0239 PERSISTENCE TO BIOLOGICAL DMARDS TNF INHIBITORS VS BIOLOGICAL DMARDS NO TNF INHIBITORS AFTER FAILURE TO SYNTHETIC CONVENTIONAL DMARDS IN RA PATIENTS TREATED IN STANDARD CLINICAL PRACTICE

Autor: J. J. Pérez Venegas, Dolores Ruiz-Montesinos, G. Jurado Quijano, I. García Hernández, A. Fernández Reboul Fernández, L. Fernández de la Fuente Bursón, I. M. Fernández-Maeztu Palacín, P. Muñoz Reinoso, Blanca Hernández-Cruz

Publikováno v: Annals of the Rheumatic Diseases. 80:1145.1-1145

Background:There are no RA response predictors for our patients. The decision to initiate a first biological depends on multiple factors such as rheumatologist experience, clinical characteristics of the patient and health system. What is clear is th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::86a686ea6b7a24393249edcdbcfe3ed6
https://doi.org/10.1136/annrheumdis-2021-eular.3920

Zobrazit plný text záznamu

AB0092 ANTISYNTHETASE SYNDROME: CLINICAL PROFILE, SEROLOGIC AND TREATMENTS USED IN A COHORT OF PATIENTS FOLLOWED AT THE VIRGEN MACARENA HOSPITAL

Autor: M. Ferrer Galván, I. García Hernández, L. Fernández de la Fuente Bursón, J. J. Pérez Venegas, F. J. Toyos Sáenz de Miera, P. Muñoz Reinoso

Publikováno v: Annals of the Rheumatic Diseases. 80:1075.1-1075

Background:The antisynthetase syndrome (SAS) is characterized by the presence of antisynthetase antibodies, anti-JO1, PL7 y PL12 are the most common; and the classic triad of myositis, arthritis, and diffuse interstitial lung disease (ILD)1. Most pat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b36c037e39c68be70336b432470c07a7
https://doi.org/10.1136/annrheumdis-2021-eular.1427

Zobrazit plný text záznamu

AB0213 SAVING GLUCOCORTICOIDS AFTER RITUXIMAB TREATMENT IN PATIENTS WITH REUMATOID ARTHRITIS. ANALYSIS OF A COMMON CLINICAL PRACTICE COHORT

Autor: L. Fernández de la Fuente Bursón, G. Jurado Quijano, V. Merino Bohóquez, P. Muñoz Reinoso, Blanca Hernández-Cruz, J. J. Pérez Venegas

Publikováno v: Annals of the Rheumatic Diseases. 80:1132.3-1133

Background:Rituximab (RTX) is a monoclonal antibody against the CD20 B cell antigen that has been used successfully in recent years for the treatment of rheumatoid arthritis (RA). It is an effective drug that reaches survival rates of 60% at 5 years

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7d2f90a7ee6ab41870d5bee7505e1706
https://doi.org/10.1136/annrheumdis-2021-eular.1362

Zobrazit plný text záznamu

AB0789 APPLICATIONS OF LOW-FIELD MAGNETIC RESONANCE IMAGING IN A RHEUMATOLOGY DEPARTMENT

Autor: L. Fernández de la Fuente Bursón, Dolores Ruiz-Montesinos, P. Muñoz Reinoso, I. M. Fernández-Maeztu Palacín, J. J. Pérez Venegas, G. Jurado Quijano

Publikováno v: Annals of the Rheumatic Diseases. 80:1420.1-1420

Background:Low-field MRI (LF-MRI) is a useful Imaging technique for the diagnosis and in the follow-up of high-impact rheumatologic pathology1. However, the use of the Low-field MRI is not widespread due to the high cost and the use of other techniqu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ac8b0b66e7a918d5c1b3a4e5eddadaf9
https://doi.org/10.1136/annrheumdis-2021-eular.1444

Zobrazit plný text záznamu

AB1027 EFFECTIVENESS OF SUBCUTANEOUS ANTI-INTERLEUCINE 6 TREATMENT IN PATIENTS WITH ACTIVE MODERATE-SEVERE GRAVES’ ORBITOPATHY REFRACTORY TO CONVENTIONAL THERAPY

Autor: M. J. Madrigal Domínguez, M. Gessa Sorroche, Dolores Ruiz-Montesinos, L. Fernández de la Fuente Bursón, J. J. Pérez Venegas, F. J. Toyos Sáenz de Miera, M. C. Díaz Ruiz

Publikováno v: Annals of the Rheumatic Diseases. 79:1806.2-1806

Background:Graves’ Orbitopathy (OG) is the main extrathyroid manifestation of Graves’ disease (GD). Up to 25% of patients have moderate-severe inflammatory activity with a risk of major sequelae. Intravenous (i.v.) glucocorticoids (GC) pulses are

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::90e6178124f293b45d627834840b18c5
https://doi.org/10.1136/annrheumdis-2020-eular.6201

Zobrazit plný text záznamu

AB1159 HIGH PREVALENCE MUSCULOSKELETAL PATHOLOGY: A CHALLENGE FOR PRIMARY ATTENDING PHYSICIANS. WHAT DO WE RHEUMATOLOGISTS CONTRIBUTE TO?

Autor: J. J. Pérez Venegas, L. Fernández de la Fuente Bursón, I. García Hernández, P. González Moreno, P. Muñoz Reinoso, Blanca Hernández-Cruz, D. V. Mendoza Mendoza

Publikováno v: Annals of the Rheumatic Diseases. 79:1870.1-1870

Background:Musculoskeletal Diseases (MSKD) represent one of the main health problems burdens worldwide. They cause a significant functional, quality of life and socioeconomic impact. Knee and lumbar osteoarthritis are the most prevalent1. MSKD can be

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::54158ae7e6fe2e7f02033fe03d27187b
https://doi.org/10.1136/annrheumdis-2020-eular.4593

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání